November/December 2018 Newsletter
In this issue:

  • Tony's Tenets: A Message from the President
  • Board Update
  • Annual Membership Survey Results
  • Public Policy Update
  • Research and Education Foundation Update
  • Affiliate Chapter News and Events
  • Featured Clinical Topic – Infectious Disease
  • Pharmacist Continuing Education Opportunities
  • Upcoming Newsletter Info
Tony’s Tenets: A Message from the MSHP President
A genuine leader is not a searcher for consensus but a molder of consensus.
-Martin Luther King, Jr.

Board Update
Elaine Ogden, PharmD, BCPS, BC-ADM
MSHP Secretary/Kansas City VA Medical Center

September Updates
  • The board discussed successes and opportunities for improvement from the Joint Fall Meeting co-hosted with MPA – overall it was a GREAT meeting!
  • Board reviewed plans for pharmacy week
  • Keep a lookout for a new practitioner group and opportunities to serve on it. They will focus on MO only list serves and mentoring programs
  • Spring meeting planning is trucking right along so save the last weekend in March to join us!!

October Updates
  • The board held a contest for a new logo – we have a winner!! Join us at Midyear for the Missouri reception on Monday 12/3 from 5:30-7:30pm in the Anaheim Marriot, Marquis Northeast Ballroom to see our new logo!
  • The board approved an external audit and hopes to have this completed by the end of the year
  • The key note speaker for Spring meeting has been selected – you will not want to miss it!
  • Our affiliates will be sending out nominations for new board members so keep a look out for serving opportunities!
Annual Membership Survey Results
The Membership and Newsletter Committees are pleased to share some of the results from the 2018 MSHP Annual Survey. This was the first year that the membership and newsletter surveys were combined. There was an excellent response this year with 102 members answering the survey.

Public Policy Update
Update to “Marijuana in Missouri-What Missouri Pharmacists Should Know” (MSHP Newsletter, Sept-Oct 2018)

As of September 27, 2018, the Drug Enforcement Agency (DEA) has rescheduled Epidiolex® to a Schedule V drug. DEA Administrator, Uttam Dhillon, provided a statement that the “DEA will continue to support sound and scientific research that promotes legitimate therapeutic uses for FDA-approved constituent components of cannabis, consistent with federal law.” 1  

On November 6, 2018, Missourians voted on three medical marijuana ballot initiatives. One of the three, Amendment 2, passed. 2 It is likely that patients have already been asking questions about how to obtain medical marijuana. Pharmacists may explain the following time table to patients. The amendment goes into effect December 6, 2018. However, the Department of Health and Senior Services (DHSS) does not have to have licensing rules in place until June 4, 2019. Additionally, they have until July 4, 2019 to begin accepting applications from “qualifying patients.” 3

Now that medical marijuana is legal in Missouri, the MSHP Public Policy Committee will be discussing the legal considerations for health-systems and pharmacies and will continue to bring legal updates on the topic to members.

The specific timeline from the Department of Health and Senior Services (DHSS) can be found at the following link: https://health.mo.gov/safety/medical-marijuana/index.php   

  1. FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act. Drug Enforcement Agency. 9/27/18. https://www.dea.gov/press-releases/2018/09/27/fda-approved-drug-epidiolex-placed-schedule-v-controlled-substance-act. Accessed 10/5/18
  2. State of Missouri General Election November 6, 2018. Unofficial Results. https://enr.sos.mo.gov/. Accessed 11/12/18.
  3. https://www.sos.mo.gov/CMSImages/Elections/Petitions/2018-051.pdf

2018 Legislative Day

MSHP sends representatives to ASHP Legislative Day and ASHP Policy Week each year. This year’s attendee’s included Roy Guharoy, Kat Miller, Lynn Eschenbacher, and Laura Butkievich. These important events allow ASHP members to promote pharmacy-related issues to legislators and lead to the development of policies that ASHP supports as an organization. 

Research & Education Foundation Update
Author: Jackie Harris, PharmD, BCPS
R&E Foundation Chair/St. Louis College of Pharmacy/Christian Hospital Northeast


Call for Publications

The MSHP Research & Education (R&E) Foundation would like to highlight the great work our members are doing. We know that there are great things that our members are doing that others could learn from. The R&E would like to highlight your scholarship in the MSHP Newsletter and e-blasts. Please share your citation to your newly published articles.

  1. Recent publication citation.
  2. Are you willing to provide a brief summary of your article that could be included in the MSHP Newsletter?
  • Yes vs. No
  1. If yes, briefly summarize your recent publication.
  2.  Contact information

Please send your publication submissions to Jim Andrews at mshp@qabs.com with the subject "Publication Call..."

Thank you sharing your latest scholarship and for progressing the practice of pharmacy in the state of Missouri.  
Affiliate Chapter News & Events
Greater Kansas City Society of Health-System Pharmacists (GKCSHP)

Upcoming Events:
January 24th: Neonatology and Cystic Fibrosis
Time TBD
Location: TBD

GKCSHP is on Instagram! Follow us @gkcshp!

President: Katie Korte , PharmD, BCPS, BCCCP
Mid-Missouri Society of Health-System Pharmacists (MMSHP)

Thank you to our student continuing education presenters: Miriam Oguejiofor, Nicholas Carpinelli, Tyler Cramer, and Kellie Harvey! 

There will not be a December meeting so our members can enjoy more time with family - Happy Holidays!

Affiliate members please check your email for details regarding our January meeting.

Like us on Facebook! www.facebook.com/mymmshp/

President: Colleen Patton , PharmD
Saint Louis Society of Health-System Pharmacists (STLSHP)

There are no upcoming events planned in the next couple months so members can focus on spending quality time with friends and family – we hope you all have a wonderful holiday season!

President: Carmen Smith , PharmD, BCPS
Southeast Missouri Society of Health-System Pharmacists (SEMSHP)

For the holidays, SEMSHP will be adopting a family. Please check your email for details.

The member networking event will be scheduled in late winter after the holidays. A continuing education opportunity will be scheduled in the Spring and will be put on by pharmacy residents from Southeast Hospital.

To join SEMSHP: http://moshp.org/join-us

President:   Ashley McCormick , PharmD, BCPS
Featured Clinical Topic:
Infectious Disease
Risks Associated with Fluoroquinolones and Alternative Agents for Empiric Therapy
Fluoroquinolones are among the most prescribed antibiotics, with a broad spectrum of activity against Gram negative organisms, some Gram-positive organisms, and sometimes Pseudomonas . These properties of fluoroquinolones combined with convenient dosing frequencies, good oral absorption, and low cost have contributed to their overutilization in clinical practice as well as the emergence of resistant strains. 1

Management of Ureaplasma
Ureaplasma is a small, self-replicating bacteria that belongs to the class of bacteria called Mollicutes or more frequently referred to by the term “atypical bacteria”. 1  
 

Nitrofurantoin and Sulfamethoxazole-Trimethoprim: Are they Safe during Pregnancy?
Antibiotics are among the most commonly prescribed medications, with a high prevalence of utilization by pregnant women. 1
 
New Antibiotic Approvals (delafloxacin and meropenem-vaborbactam)
For many years, development of novel antimicrobials seemed to be at a standstill. This, combined with increasing rates antimicrobial resistance, left a very real threat that there may come a time when the antimicrobials in our arsenal will no longer be effective against deadly pathogens.
 
Pharmacist Continuing Education
Pharmacogenetic Testing to Predict Warfarin Response

Author: Kristine Reckenberg, PharmD
PGY1 Pharmacy Practice Resident
Preceptor: Justinne Guyton, PharmD, BCACP
PGY1 Pharmacy Practice Residency Director
St. Louis County Department of Public Health/St. Louis College of Pharmacy

Program Number: 2018-11-05
Approval Dates: December 1, 2018 to June 1, 2019
Approved Contact Hours: One (1) CE(s) per LIVE session. 

Current Recommendations for the Use of Antiplatelet Therapy in Secondary Prevention of Non-Cardioembolic Ischemic Stroke

Author: Sarah Tortora, PharmD
PGY1 Pharmacy Practice Resident
Preceptor: Jackie Harris, PharmD, BCPS
PGY1 Pharmacy Practice Residency Director
Christian Hospital Northeast – St Louis, MO

Program Number: 2018-11-04
Approval Dates: December 1, 2018 to June 1, 2019
Approved Contact Hours: One (1) CE(s) per LIVE session.


Upcoming Newsletter Info
January/February 2018 Newsletter

Featured Clinical Topic:  Endocrinology

Submit to: Sarah Cook
Upcoming Featured Clinical Topics

Jan/Feb: Endocrinology
Mar/Apr: Psych/Neuro/Pain
May/June: Critical Care/Pulmonology/Emergency Med
July/Aug: Cardiology/Anticoagulation
Sept/Oct: Oncology
Nov/Dec: Infectious Disease/Vaccines 
Newsletter Submission Guidelines
  • Pharmacists, pharmacy technicians, and pharmacy students in Missouri are eligible to submit content for publication in the MSHP Newsletter. Student submissions need to include pharmacist oversight.
  • Submit content to the current Newsletter Committee Chair on or before the established deadlines.
  • CE and Featured Clinical Topics must be approved by the Newsletter Committee Chair in advance of article submission, to prevent duplicates. Duplicate articles submitted without advanced approval may not be published.
  • Recommended length of submissions for committee, affiliate, college/schools of pharmacy, and student chapter reports is half to one page in length.
  • Recommended length of submissions for featured clinical topics is 1 to 2 pages, without references.
  • Recommended length of CE articles is individualized, based on the amount of CE provided.
  • Recommended length of submission for other categories is 1 to 2 pages.
Newsletter Submission Deadlines
  • Jan./Feb. 2019: January 14th
  • March/April 2019: March 11th
  • May/June 2019: May 13th
  • July/Aug. 2019: July 8th
  • Sept./Oct. 2019: September 9th
  • Nov./Dec. 2019: November 11th
Is there a Pharmacy Best Practice happening at your institution? Would you like to share your successes with MSHP Membership? We'd love to highlight your institution in a future MSHP Newsletter!

Please contact the MSHP Newsletter Chair, Sarah Cook
Interested in becoming a MSHP member or need to renew? It's easy! Click the above button or visit the MSHP website: www.moshp.org/join-us

Membership Dues:
Pharmacist: $110
Joint Pharmacist: (Married Couple) $155
Technician: $35
Associate Member: $110
Recent Graduate (within 24 months): $45
Student: $25
Retired Pharmacist: $35
MSHP Board of Directors
2018 - 2019
President: Tony Huke
President-Elect: Alex Oschman
Immediate Past President: Jeremy Hampton
Secretary: Elaine Ogden
MSHP Committee Chairs
2018-2019
Vendor Relations Board Liaison -  Evanna Shopoff
Membership Committee -  Ashley Evans
Communications Committee -  Elaine Ogden
Public Policy Committee -  Sarah Cox
Newsletter Committee -  Sarah Cook
Education and Programming -  Elizabeth Englin
Website Committee -  Kathryn Burnett
Questions/Comments
If you have any questions, comments, or wish to submit an article to for MSHP Newsletter, please contact the Newsletter Committee Chair:
Sarah Cook or another Newsletter Committee member.

2018-2019 MSHP Newsletter Committee Members
Sarah Cook, PharmD, BCPS (Chair)
Laura Challen, PharmD, MBA, BCPS, BCACP (Vice-Chair)
Barb Kasper, PharmD, BCACP
Hannah Pope, PharmD, BCPS
Emily Shor, PharmD